TrademarkDir
ALBUMEDIX
LIVE

Serial Number

79202497

Owner

ALBUMEDIX A/S

Attorney

Karen Lim

Filing Date

Aug 15, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ALBUMEDIX Trademark

Serial Number: 79202497 • Registration: 5388817

ALBUMEDIX is a trademark filed by ALBUMEDIX A/S on August 15, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ALBUMEDIX A/S (13 trademarks)

LOTTENBORGVEJ 26
LYNGBY , DK

Entity Type: 11

Albumedix Ltd (16 trademarks)

HQ, Mabel Street

Entity Type: 99

Trademark Details

Filing Date

August 15, 2016

Registration Date

January 30, 2018

Published for Opposition

November 14, 2017

Goods & Services

Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for medical use and pharmaceutical medicinal use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin for pharmaceutical and medical purposes; diagnostic agents for medical imaging * [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient * ]

Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents

Research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 16, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 16, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 16, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Nov 19, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Nov 19, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 23, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
Jan 12, 2024 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 30, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2023 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 4, 2021 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 11, 2021 INPR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 23, 2021 ADCH
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Feb 11, 2021 CORR
CORRECTION UNDER SECTION 7 - PROCESSED
Feb 11, 2021 COC.
ASSIGNED TO PARALEGAL
Feb 11, 2021 PLGL
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 23, 2020 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 23, 2020 COC.
ASSIGNED TO PARALEGAL
Nov 23, 2020 PLGL
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 3, 2020 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Jul 3, 2020 LIMG
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2020 REAP
CHANGE OF OWNER RECEIVED FROM IB
Oct 11, 2018 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 6, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 8, 2018 FICS
FINAL DISPOSITION PROCESSED
May 8, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2018 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 23, 2017 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 6, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 4, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 4, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 4, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2017 CRFA
ASSIGNED TO LIE
Sep 13, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 6, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 6, 2017 REAP
REFUSAL PROCESSED BY IB
Mar 25, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Mar 7, 2017 MAFR
NON-FINAL ACTION WRITTEN
Mar 6, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 2, 2017 REPR

Related Trademarks

More from this Owner

RECOMBUMIN

RECOMBUMIN

RECOMBUMIN

RECOMBUMIN

RECOMBUMIN

RECOMBUMIN

ALBUMEDIX

ALBUMEDIX

ALBUMEDIX

ALBUMEDIX

ALBUMEDIX

ALBUMEDIX